Business

India’s Lupin settles US patent dispute with Astellas Pharma for $90 million

Published

on


India’s Lupin settles US patent dispute with Astellas Pharma for $90 million

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version